World's Best Scientists 2026 revealed!
Takahiro Yamazaki

Takahiro Yamazaki

D-Index & Metrics

Immunology

D-Index
47
Citations
21128
World Ranking
4463
National Ranking
2019

Overview

Takahiro Yamazaki is a researcher affiliated with Cornell University in the United States. Their scientific work primarily spans the fields of Medicine, Biochemistry, Genetics and Molecular Biology, and Immunology and Microbiology. Their research is further specialized in subfields such as Immunology, Oncology, Molecular Biology, Epidemiology, and Physiology.

The main topics of Takahiro Yamazaki's research include cancer immunotherapy and biomarkers, immunotherapy and immune responses, autophagy in disease and therapy, RNA interference and gene delivery, interferon and immune responses, CAR-T cell therapy research, and advanced breast cancer therapies.

They have contributed to a number of publications in various scientific venues. Frequent publication venues include:

  • Methods in cell biology
  • OncoImmunology
  • Communications Biology
  • Regular and Young Investigator Award Abstracts
  • Journal for ImmunoTherapy of Cancer

Some of Takahiro Yamazaki's recent papers are:

  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death, 2020, Journal for ImmunoTherapy of Cancer
  • Detection of immunogenic cell death and its relevance for cancer therapy, 2020, Cell Death and Disease
  • Mitochondrial control of inflammation, 2022, Nature reviews. Immunology
  • Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy, 2020, Nature Immunology
  • Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control, 2021, Journal of Clinical Investigation

Throughout their research career, Takahiro Yamazaki has collaborated frequently with several co-authors, including:

  • Lorenzo Galluzzi
  • Aitziber Buqué
  • Norma Bloy
  • Ai Sato
  • Silvia C. Formenti

Best Publications

  • Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

    Marie Vétizou;Marie Vétizou;Marie Vétizou;Jonathan M. Pitt;Jonathan M. Pitt;Jonathan M. Pitt;Romain Daillère;Romain Daillère;Romain Daillère;Patricia Lepage

  • The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide

    Sophie Viaud;Sophie Viaud;Fabiana Saccheri;Grégoire Mignot;Takahiro Yamazaki

  • Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

    Antonella Sistigu;Takahiro Yamazaki;Erika Vacchelli;Kariman Chaba

  • Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors

    Jonathan M. Pitt;Marie Vétizou;Marie Vétizou;Marie Vétizou;Romain Daillère;Romain Daillère;Romain Daillère;María Paula Roberti

  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Lorenzo Galluzzi;Ilio Vitale;Sarah Warren;Sandy Adjemian

  • Detection of immunogenic cell death and its relevance for cancer therapy

    Jitka Fucikova;Oliver Kepp;Lenka Kasikova;Giulia Petroni

  • Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy

    Christina Pfirschke;Camilla Engblom;Steffen Rickelt;Virna Cortez-Retamozo

  • Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

    Romain Daillère;Romain Daillère;Romain Daillère;Marie Vétizou;Marie Vétizou;Marie Vétizou;Nadine Waldschmitt;Takahiro Yamazaki;Takahiro Yamazaki

  • Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells.

    Yuting Ma;Yuting Ma;Yuting Ma;Sandy Adjemian;Sandy Adjemian;Sandy Adjemian;Stephen R. Mattarollo;Takahiro Yamazaki;Takahiro Yamazaki;Takahiro Yamazaki

  • Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance

    Federico Pietrocola;Federico Pietrocola;Jonathan Pol;Erika Vacchelli;Erika Vacchelli;Shuan Rao

  • Linking cellular stress responses to systemic homeostasis

    Lorenzo Galluzzi;Takahiro Yamazaki;Guido Kroemer

  • An immunosurveillance mechanism controls cancer cell ploidy

    Laura Senovilla;Laura Senovilla;Laura Senovilla;Ilio Vitale;Ilio Vitale;Ilio Vitale;Isabelle Martins;Isabelle Martins;Isabelle Martins;Maximilien Tailler;Maximilien Tailler;Maximilien Tailler

  • Cardiac Glycosides Exert Anticancer Effects by Inducing Immunogenic Cell Death

    Laurie Menger;Erika Vacchelli;Erika Vacchelli;Erika Vacchelli;Sandy Adjemian;Sandy Adjemian;Sandy Adjemian;Isabelle Martins;Isabelle Martins;Isabelle Martins

  • Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy.

    Takahiro Yamazaki;Alexander Kirchmair;Ai Sato;Aitziber Buqué

  • Crizotinib-induced immunogenic cell death in non-small cell lung cancer

    Peng Liu;Liwei Zhao;Jonathan Pol;Sarah Levesque

  • Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists

    Takahiro Yamazaki;Dalil Hannani;Vichnou Poirier-Colame;Sylvain Ladoire

  • A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1

    Shin Foong Ngiow;Arabella Young;Arabella Young;Nicolas Jacquelot;Takahiro Yamazaki

  • Crosstalk between ER stress and immunogenic cell death.

    Oliver Kepp;Laurie Menger;Laurie Menger;Laurie Menger;Erika Vacchelli;Erika Vacchelli;Erika Vacchelli;Clara Locher;Clara Locher

  • Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade

    Nicolas Jacquelot;Takahiro Yamazaki;Maria P. Roberti;Connie P.M. Duong

  • Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control.

    Claire Lhuillier;Nils Petter Rudqvist;Takahiro Yamazaki;Tuo Zhang

  • Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy

    Heng Yang;Yuting Ma;Guo Chen;Heng Zhou

Frequent Co-Authors

Lorenzo Galluzzi
Lorenzo Galluzzi Cornell University
Guido Kroemer
Guido Kroemer Université Paris Cité
Laurence Zitvogel
Laurence Zitvogel University of Paris-Saclay
Oliver Kepp
Oliver Kepp Institut Gustave Roussy
Yuting Ma
Yuting Ma University of Oxford
Mark J. Smyth
Mark J. Smyth QIMR Berghofer Medical Research Institute
Erika Vacchelli
Erika Vacchelli Université Paris Cité
Aurélien Marabelle
Aurélien Marabelle Institut Gustave Roussy
Isabelle Martins
Isabelle Martins Inserm : Institut national de la santé et de la recherche médicale
Laura Senovilla
Laura Senovilla University of Valladolid

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees online can open diverse career paths. Many professionals consider advanced nursing programs as a stepping stone into specialized medical fields. Programs like the cheapest psych np programs offer an affordable route for nurses aiming to expand their expertise into psychiatric care, a field closely linked to immunological health.

Understanding earning potential can guide career decisions. For example, knowing how much do dnp nurses make helps prospective students evaluate the return on investment of pursuing a Doctor of Nursing Practice degree, which can complement immunology knowledge in clinical or research roles.

Transitioning roles is also a critical consideration. Programs such as those designed for an fnp to acute care np bridge program provide structured paths for Family Nurse Practitioners to shift into acute care settings, where immunological expertise is often essential.

Finally, accelerated nursing programs can fast-track careers. The accelerated np programs online enable qualified candidates to efficiently gain the credentials needed to work in specialties that intersect with immunology, enhancing both clinical skills and professional prospects.

Best Scientists Citing Takahiro Yamazaki

Trending Scientists